Pfizer Reaches Settlement In Drug-Risk Securities Suit
By Bonnie Eslinger ( July 19, 2016, 11:01 PM EDT) -- Pfizer told the Second Circuit Tuesday it had reached a settlement in a securities class action over the alleged risks of two of its drugs and asked that its petition for a rehearing on the appellate court's April decision reviving the case be postponed....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.